Álvarez, R.S.; Gómez, F.D.; Zotta, E.; Paton, A.W.; Paton, J.C.; Ibarra, C.; Sacerdoti, F.; Amaral, M.M.
Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome. Toxins 2021, 13, 536.
https://doi.org/10.3390/toxins13080536
AMA Style
Álvarez RS, Gómez FD, Zotta E, Paton AW, Paton JC, Ibarra C, Sacerdoti F, Amaral MM.
Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome. Toxins. 2021; 13(8):536.
https://doi.org/10.3390/toxins13080536
Chicago/Turabian Style
Álvarez, Romina S., Fernando D. Gómez, Elsa Zotta, Adrienne W. Paton, James C. Paton, Cristina Ibarra, Flavia Sacerdoti, and María M. Amaral.
2021. "Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome" Toxins 13, no. 8: 536.
https://doi.org/10.3390/toxins13080536
APA Style
Álvarez, R. S., Gómez, F. D., Zotta, E., Paton, A. W., Paton, J. C., Ibarra, C., Sacerdoti, F., & Amaral, M. M.
(2021). Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome. Toxins, 13(8), 536.
https://doi.org/10.3390/toxins13080536